Harel Insurance Investments & Financial Services Ltd. P Lx Pharma Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$4.93 - $7.2 $1.23 Million - $1.8 Million	-250,000 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$1.22 - $4.38 $366,000 - $1.31 Million	-300,000 Reduced 54.55%	250,000 $383,000
Q4 2017 Feb 01, 2018	BUY	$6.3 - $9.1 $1.89 Million - $2.73 Million	300,000 Added 120.0%	550,000 $361,000
Q3 2017 Nov 02, 2017	BUY	$6.08 - $7.0 $1.52 Million - $1.75 Million	250,000	250,000 $145,000

Others Institutions Holding PLXP

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About PLx Pharma Inc.

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

More about PLXP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account